Scoparone attenuates PD-L1 expression in human breast cancer cells by MKP-3 upregulation.
Scoparone (SCO) downregulates PD-L1 expression in breast cancer cells via AKT inhibition and upregulation of MKP-3 expression. SCO could be a potential combinatorial agent for cancer immunotherapy.
- Kim SW, Kim CW and Kim HS (2024).
- Anim Cells Syst (Seoul).
- PubMed:
- 38348341